Study underway to evaluate immunotherapy plus radiation for newly diagnosed sarcoma – Healio
|
Study underway to evaluate immunotherapy plus radiation for newly diagnosed sarcoma
Healio A clinical trial is underway to assess use of two immunotherapy agents, durvalumab and tremelimumab, plus radiation therapy for the treatment of newly diagnosed high-risk sarcoma. The goal of the Neoadjuvant XRT Immunotherapy and Surgery for Soft … |
